Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase for Severe Submassive Pulmonary Embolism
NCT00680628Phase 3Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2008
- Primary completion
- May 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in pulmonary embolism (PE), sponsored by Wake Forest University Health Sciences. Started May 2008; status: terminated.
02
Drugs
tenecteplase
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00680628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680628.